Science and Research

Immunogenic properties of the human gut-associated archaeon Methanomassiliicoccus luminyensis and its susceptibility to antimicrobial peptides

The methanogenic archaeon Methanomassiliicoccus luminyensis strain B10T was isolated from human feces just a few years ago. Due to its remarkable metabolic properties, particularly the degradation of trimethylamines, this strain was supposed to be used as "Archaebiotic" during metabolic disorders of the human intestine. However, there is still no data published regarding adaptations to the natural habitat of M. luminyensis as it has been shown for the other two reported mucosa-associated methanoarchaea. This study aimed at unraveling susceptibility of M. luminyensis to antimicrobial peptides as well as its immunogenicity. By using the established microtiter plate assay adapted to the anaerobic growth requirements of methanogenic archaea, we demonstrated that M. luminyensis is highly sensitive against LL32, a derivative of human cathelicidin (MIC = 2 muM). However, the strain was highly resistant against the porcine lysin NK-2 (MIC = 10 muM) and the synthetic antilipopolysaccharide peptide (Lpep) (MIC>10 muM) and overall differed from the two other methanoarchaea, Methanobrevibacter smithii and Methanosphaera stadtmanae in respect to AMP sensitivity. Moreover, only weak immunogenic potential of M. luminyensis was demonstrated using peripheral blood mononuclear cells (PBMCs) and monocyte-derived dendritic cells (moDCs) by determining release of pro-inflammatory cytokines. Overall, our findings clearly demonstrate that the archaeal gut inhabitant M. luminyensis is susceptible to the release of human-derived antimicrobial peptides and exhibits low immunogenicity towards human immune cells in vitro-revealing characteristics of a typical commensal gut microbe.

  • Bang, C.
  • Vierbuchen, T.
  • Gutsmann, T.
  • Heine, H.
  • Schmitz, R. A.

Keywords

  • Anti-Infective Agents/*pharmacology
  • Humans
  • Intestines/*microbiology
  • Methanomicrobiaceae/drug effects/growth & development/*immunology
  • Peptides/*pharmacology
Publication details
DOI: 10.1371/journal.pone.0185919
Journal: PloS one
Pages: e0185919 
Number: 10
Work Type: Original
Location: ARCN
Disease Area: AA
Partner / Member: FZB
Access-Number: 28982164
See publication on PubMed

DZL Engagements

chevron-down